Min-Jeong Kim Selected Research

HCE

4/2022	Specific Detection of Acanthamoeba species using Polyclonal Peptide Antibody Targeting the Periplasmic Binding Protein of A. castellanii.
2/2022	Characterization of a Peptide Antibody Specific to the Adenylyl Cyclase-Associated Protein of Acanthamoeba castellanii.
1/2022	Detection of Acanthamoeba spp. using carboxylesterase antibody and its usage for diagnosing Acanthamoeba-keratitis.
1/2021	Chorismate mutase peptide antibody enables specific detection of Acanthamoeba.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min-Jeong Kim Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 07/2022 - 03/2008
7	Neoplasms (Cancer) 01/2018 - 12/2003
5	Inflammation (Inflammations) 05/2020 - 04/2009
5	Stomach Neoplasms (Stomach Cancer) 01/2018 - 02/2009
4	Cognitive Dysfunction 07/2022 - 02/2009
4	Infections 01/2022 - 11/2009
4	Neuroinflammatory Diseases 02/2021 - 05/2020
3	Cysts 11/2022 - 01/2022
3	Keratitis 04/2022 - 01/2021
3	Adenocarcinoma 01/2021 - 04/2016
3	Rectal Neoplasms (Rectal Cancer) 10/2016 - 05/2013
3	Parkinson Disease (Parkinson's Disease) 01/2016 - 10/2008
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2013 - 12/2009
3	Hypertension (High Blood Pressure) 12/2009 - 01/2008
2	Obesity 07/2022 - 01/2018
2	Body Weight (Weight, Body) 02/2022 - 08/2015
2	Rheumatoid Arthritis 05/2020 - 05/2017
2	Insulin Resistance 01/2020 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 04/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 07/2014
2	Hypersensitivity (Allergy) 12/2016 - 01/2016
2	Disease Progression 10/2016 - 02/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2016 - 03/2013
2	Ganglion Cysts (Ganglion) 09/2010 - 09/2006
1	Parasitic Diseases (Parasitic Disease) 11/2022
1	Osteoporosis 06/2022
1	Non-alcoholic Fatty Liver Disease 02/2022
1	Type 2 Diabetes Mellitus (MODY) 02/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Blindness (Hysterical Blindness) 01/2022
1	Acanthamoeba Keratitis 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 09/2021
1	Listeriosis (Listeria Infection) 04/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Amyloid Plaque 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Hemorrhage 12/2020
1	Kidney Calculi (Kidney Stone) 12/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2008
7	Biomarkers (Surrogate Marker)IBA 07/2022 - 07/2013
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 10/2009
4	Pharmaceutical PreparationsIBA 11/2022 - 10/2011
4	HCEIBA 04/2022 - 01/2021
4	Docetaxel (Taxotere)FDA Link 04/2016 - 02/2009
3	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2008
3	Therapeutic UsesIBA 01/2021 - 01/2016
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 01/2016
3	CalciumIBA 12/2009 - 10/2007
3	Translationally-Controlled 1 Tumor ProteinIBA 12/2009 - 01/2008
2	Hormones (Hormone)IBA 06/2022 - 01/2020
2	Gemcitabine FDA Link 01/2021 - 04/2015
2	LipopolysaccharidesIBA 05/2020 - 10/2018
2	Phosphates (Orthophosphate)IBA 01/2020 - 05/2013
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 01/2016
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2018 - 07/2014
2	tanshinoneIBA 01/2018 - 07/2014
2	Bee Venoms (Bee Venom)IBA 12/2016 - 01/2016
2	S 1 (combination)IBA 04/2016 - 04/2015
2	11-octadecenoic acid (vaccenic acid)IBA 01/2016 - 08/2015
2	VaccinesIBA 01/2012 - 11/2009
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2010 - 09/2006
2	Adenosine Triphosphatases (ATPase)IBA 12/2009 - 01/2008
2	Phosphotransferases (Kinase)IBA 03/2008 - 12/2003
1	Chloroquine (Aralen)FDA LinkGeneric 11/2022
1	Histone Deacetylase InhibitorsIBA 11/2022
1	polihexanideIBA 11/2022
1	PowdersIBA 07/2022
1	Triglycerides (Triacylglycerol)IBA 07/2022
1	HDL CholesterolIBA 07/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2022
1	TeaIBA 07/2022
1	oxidized low density lipoproteinIBA 07/2022
1	LDL CholesterolIBA 07/2022
1	Transcription Factors (Transcription Factor)IBA 07/2022
1	Alanine Transaminase (SGPT)IBA 07/2022
1	Estrogens (Estrogen)FDA Link 06/2022
1	AntibodiesIBA 04/2022
1	dulaglutideIBA 02/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 02/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Carboxylesterase (Hydrolase S)IBA 01/2022
1	Pattern Recognition ReceptorsIBA 09/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2021
1	Riboflavin (Vitamin B2)FDA LinkGeneric 04/2021
1	Prostaglandins EIBA 02/2021
1	Conditioned Culture MediaIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	SaponinsIBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2020

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2021 - 10/2009
6	Therapeutics 12/2020 - 12/2009
3	Chemoradiotherapy 10/2016 - 05/2013
2	Radiotherapy 10/2016 - 08/2016
2	Neoadjuvant Therapy 08/2011 - 12/2009
2	Liver Transplantation 08/2011 - 03/2007
1	Transcranial Direct Current Stimulation 07/2022
1	Contact Lenses 01/2022
1	Oral Administration 02/2021